Home > Insider Trading > Filing (0001415889-24-030182)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2010019	Solomon Moshkevich	C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753	President, Clinicaldiagnostics	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-12-20	1,675	$0.00	116,381	No	4	A	Direct
Common Stock	Acquisiton	2024-12-20	3,044	$0.00	119,425	No	4	A	Direct
Common Stock	Disposition	2024-12-23	2	$158.06	119,423	No	4	S	Direct
Common Stock	Disposition	2024-12-23	3	$158.19	119,420	No	4	S	Direct
Common Stock	Disposition	2024-12-23	2,423	$159.60	116,997	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

On October 22, 2021, the Reporting Person was granted Restricted Stock Units ("RSUs") covering 10,000 shares of Common Stock which vest in tranches upon the achievement of certain milestones relating to a combination of the passage of time and certain business performance criteria. On December 20, 2024, the criteria was satisfied for the vesting of RSUs covering 1,675 shares of Common Stock.
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
On August 30, 2024, the Reporting Person was granted RSUs covering 3,044 shares of Common Stock which vest upon the achievement of certain milestones relating to a combination of the passage of time and certain business performance criteria. On December 20, 2024, the criteria was satisfied for the vesting of RSUs covering 3,044 shares of Common Stock.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on October 22, 2021 and August 30, 2024, respectively.